Fecal calprotectin as a biomarker of microscopic bowel inflammation in patients with spondyloarthritis-Reference-Cited by-同舟云学术

Fecal calprotectin as a biomarker of microscopic bowel inflammation in patients with spondyloarthritis

Published:2022-07-18 Issue:9 Volume:25 Page:1078-1086
ISSN:1756-1841
Container-title:International Journal of Rheumatic Diseases
language:en
Short-container-title:Int J of Rheum Dis

Author:

Campos Júlia Faria¹^ORCID,Resende Gustavo Gomes²,Barbosa Alfredo José Afonso³,de Carvalho Silas Castro⁴,Lage Junia Aguiar⁵,Cunha Pedro Ferrari Sales⁵,de Souza Stela Cristina Silva⁵,Ferrari Maria de Lourdes Abreu⁶

Affiliation:

1. Instituto Alfa de Gastroenterologia, Hospital das Clínicas Universidade Federal de Minas Gerais Belo Horizonte Brazil

2. Departamento de Reumatologia, Hospital das Clínicas Universidade Federal de Minas Gerais Belo Horizonte Brazil

3. Departamento de Patologia Clínica, Faculdade de Medicina Universidade Federal de Minas Gerais Belo Horizonte Brazil

4. Departamento de Endoscopia Digestiva Universidade Federal de Minas Gerais Belo Horizonte Brazil

5. Faculdade de Medicina Universidade Federal de Minas Gerais Belo Horizonte Brazil

6. Departamento de Clínica Médica, Faculdade de Medicina Universidade Federal de Minas Gerais Belo Horizonte Brazil

Publisher

Wiley

Subject

Rheumatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1756-185X.14388

Reference36 articles.

1. Mucosal Inflammation in Spondylarthritides: Past, Present, and Future

2. Calprotectin in ankylosing spondylitis – frequently elevated in feces, but normal in serum

3. Microscopic gut inflammation in axial spondyloarthritis: a multiparametric predictive model

4. The gut in spondyloarthritis

5. The transition of acute to chronic bowel inflammation in spondyloarthritis

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Calprotectin as a companion biomarker for colorectal cancer: A lesson from microscopic bowel inflammation;International Journal of Rheumatic Diseases;2023-03-27

2. Patient-tailored dose reduction of tumor necrosis factor inhibitors in axial spondyloarthritis;International Immunopharmacology;2023-03

3. Managing Inflammatory Bowel Disease in Spondyloarthritis;Rheumatology;2023

4. Comment on fecal calprotectin as a biomarker of microscopic bowel inflammation in patients with spondyloarthritis;International Journal of Rheumatic Diseases;2022-10-14